Viveash Dawn 4
4 · Orexigen Therapeutics, Inc. · Filed Jan 20, 2011
Insider Transaction Report
Form 4
Viveash Dawn
Head of Regulatory Affairs
Transactions
- Award
Stock Option (right to buy)
2011-01-18+35,000→ 35,000 totalExercise: $9.31Exp: 2021-01-17→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each one-month period of the reporting persons service as an employee, director or consultant following 1/18/2011, so that all of the shares of the stock subject to the option shall be vested on 1/18/2015, subject to the reporting persons continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.
- [F2]Not applicable.